Siyuan Hou

Nanjing, 211100, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

A potent anti-CD47 antibody decoupling anti-tumor efficacy from hematotoxicity.

A potent anti-CD47 antibody decoupling anti-tumor efficacy from hematotoxicity.

Journal: International immunopharmacology
Published: May 20, 2026

Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer.

Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer.

Journal: Cell reports. Medicine
Published: September 16, 2025

Self-interacting dark matter with mass segregation: a unified explanation of dwarf cores and small-scale lenses.

Self-interacting dark matter with mass segregation: a unified explanation of dwarf cores and small-scale lenses.

Journal: Science bulletin
Published: July 29, 2025

Vitamin D receptor (VDR) mediates the quiescence of activated hepatic stellate cells (aHSCs) by regulating M2 macrophage exosomal smooth muscle cell-associated protein 5 (SMAP-5).

Vitamin D receptor (VDR) mediates the quiescence of activated hepatic stellate cells (aHSCs) by regulating M2 macrophage exosomal smooth muscle cell-associated protein 5 (SMAP-5).

Journal: Journal of Zhejiang University. Science. B
Published: March 14, 2023

Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals.

Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals.

Journal: ACS nano
Published: January 03, 2023

Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.

Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.

Journal: Nano letters
Published: November 08, 2021

Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.

Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.

Journal: Journal of medicinal chemistry
Published: December 31, 2020

Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].

Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].

Journal: European journal of medicinal chemistry
Published: December 04, 2019

Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.

Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.

Journal: Science translational medicine
Published: September 28, 2019

Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton.

Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton.

Journal: Journal of medicinal chemistry
Published: October 24, 2018

Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.

Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.

Journal: European journal of medicinal chemistry
Published: October 22, 2018

Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1.

Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1.

Journal: The Journal of endocrinology
Published: July 19, 2018
Showing 1-12 of 18

Last Updated: 09/26/2026